Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
about
Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureusReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsInhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureusRegulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583Characteristics of the Clostridium difficile cell envelope and its importance in therapeuticsCross-membranes orchestrate compartmentalization and morphogenesis in Streptomyces.Molecular Basis of Vancomycin Dependence in VanA-Type Staphylococcus aureus VRSA-9Structural and Functional Characterization of VanG D-Ala:D-Ser Ligase Associated with Vancomycin Resistance in Enterococcus faecalisEurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTIONTargeting Antibiotic ResistanceVancomycin resistant enterococci in farm animals - occurrence and importanceVancomycin resistance in gram-positive cocciGenome-Wide Identification of Antimicrobial Intrinsic Resistance Determinants in Staphylococcus aureusRoles for MreC and MreD proteins in helical growth of the cylindrical cell wall in Bacillus subtilisCombinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureusAntimicrobial Susceptibility of Enteric Gram Negative Facultative Anaerobe Bacilli in Aerobic versus Anaerobic ConditionsPhage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF.Panel of Bacillus subtilis reporter strains indicative of various modes of actionSpecificity of L,D-transpeptidases from gram-positive bacteria producing different peptidoglycan chemotypes.Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptidesRole of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors.Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa.Highly Deviated Asymmetric Division in Very Low Proportion of Mycobacterial Mid-log Phase Cells.VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405Bacterial membrane activity of α-peptide/β-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains.Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications.Glycopeptide antibiotic biosynthesis: enzymatic assembly of the dedicated amino acid monomer (S)-3,5-dihydroxyphenylglycine.Molecular detection of antimicrobial resistanceTwo-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditisA periplasmic D-alanyl-D-alanine dipeptidase in the gram-negative bacterium Salmonella entericaCharacterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339.Regulation of expression of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroideGlycopeptide resistance vanA operons in Paenibacillus strains isolated from soilRegulation of VanA- and VanB-type glycopeptide resistance in enterococciInducible expression eliminates the fitness cost of vancomycin resistance in enterococci.Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.Purification and characterization of the VanB ligase associated with type B vancomycin resistance in Enterococcus faecalis V583.
P2860
Q21133515-4ACDA750-B920-47DD-81D6-26ACBA8321A5Q24556635-1D41FA5F-7058-4623-862F-F2B2C280ACDEQ24646677-A3386F34-3D4C-42EE-9D7C-C44E456A852AQ24679159-0C998323-B0BD-44E0-9710-7F52C105AAB7Q24684562-5FBC13B9-AC8A-42B3-834E-DF367850242DQ26745652-FCD45F05-3DFF-4D1E-BB65-9598E68E1C53Q27313813-4F2F1304-30F8-4A01-A6B3-946D4889A095Q27664123-BFED6BA2-56B2-4F11-8FA8-290BE3B05EDCQ27672938-8F75161A-FE4C-4E58-88AA-55D433B4FFD1Q27674703-3E655564-100B-41BB-A2C1-E762CA0E6D1DQ28078130-4AE3C25C-569B-42D6-BC99-7FF960F49293Q28274515-583A1591-F875-4D73-8B7C-1840065E32CDQ28284820-2F368A7C-A091-414B-B2FE-78CD7A493A85Q28354064-BC645E49-FD08-497C-BCC6-92E9E74A1ADDQ28489009-4C9CD99A-46D5-4F51-9690-09550995EC35Q28543476-33B45A75-9B60-4918-9AFD-438658110AB0Q28552167-AA33FF50-F8B0-459E-AD38-27A93476E6BBQ30855747-69AACCD3-FF7D-48B8-9F7D-D4B70B698C7BQ31081404-049256EE-24CD-4D6F-8641-C46737124BFAQ31101895-7722D9E9-9A56-47D1-9457-E1F6738D2DC7Q33661713-895F6B95-E7AD-4527-BFE3-AE5898D51791Q33750776-AE2492FA-84BC-43DD-BA49-BA9BFF6BAC7BQ33757521-A006A4BD-F649-4846-8D42-17629CD4740DQ33774311-6F006A5B-41BF-4807-9135-9A4DE6DC7B05Q33775698-3ABDE400-57D0-4D7F-A36F-52E1BA60C9E0Q33872930-24158E20-8B48-4ED2-A2E1-D84EED309CE1Q33938698-B254F905-FD7D-4344-8004-3EF729B9AB12Q33944429-E59002FA-6C2D-4333-A04A-273D7E4F5040Q33952741-3D0645BA-5A04-42B8-BC15-0A2070EDB6D9Q33975793-55F1CE8E-527D-4C9C-A67E-400A5B5C139AQ33976375-027E7386-F512-4594-BB43-E109C0BDA240Q33991633-5D3639D3-3924-46C6-9EDF-7D8F2C038269Q33992284-CEC2635D-7E3B-4FD0-80C9-E8B4F5F0A208Q34011872-D88F203F-0716-4CEE-9825-41EB63C321B6Q34060614-790DAE66-184E-4730-A716-9C7683CE15E1Q34077130-81A25BB0-CA1B-427A-88C0-2675B260BD4BQ34131478-D47ED6B0-066D-4683-AA77-4FA56F972282Q34165648-AAD6488E-1CB5-4678-A170-7D06B0105B44Q34318471-2CC12F9D-26C6-4D03-86FE-BCE28A7B603FQ34325407-D2D8F875-381D-49D3-A0E5-96E7ECECECB2
P2860
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@ast
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@en
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@nl
type
label
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@ast
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@en
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@nl
prefLabel
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@ast
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@en
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@nl
P356
P1476
Structure, biochemistry and mechanism of action of glycopeptide antibiotics.
@en
P2093
Reynolds PE
P2888
P304
P356
10.1007/BF01967563
P577
1989-11-01T00:00:00Z
P6179
1048970846